START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients
Keywords: درمان درمانی درمانی; Medication therapy management; Pharmacogenetics; Phenylketonuria; PKU; Tetrahydrobiopterin; Sapropterin dihydrochloride